Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Spectrum Names Commercial Ops VP | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Spectrum Names Commercial Ops VP

Turgeon brings 25 years of pharma sales experience

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Joseph Turgeon has been appointed senior vice president of sales and commercial operations at Spectrum Pharmaceuticals. Mr. Turgeon will be responsible for the commercialization and sales of all Spectrum products, including Fusilev (levoleucovorin) for injection, Foloyn (pralatrexate injection), and Zevalin (ibritumomab tiuxetan) injection for intravenous use. Mr. Turgeon brings over 25 years of pharma sales experience, including various executive leadership roles at Amgen. He will report to Ken Keller, executive vice president and chief operating officer.

“With three anticancer drugs on the market now bringing nearly $300 million in pro forma revenue and nearly 10 drugs in clinical development, we are committed to strong growth in the next five years,” said Rajesh C. Shrotriya, M.D., chairman, president and chief executive officer of Spectrum Pharmaceuticals, Inc. “The addition of Mr. Turgeon following the appointment of Mr. Keller earlier this year is part of a planned strategy for expedited growth of Spectrum Pharmaceuticals.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters